Ethmozine® (moricizine HCl) therapy for complex ventricular arrhythmias
- 1 October 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 60 (11) , 59-66
- https://doi.org/10.1016/0002-9149(87)90723-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antiarrhythmic Drug Therapy (Part 1) Benefits and HazardsChest, 1985
- Treatment of ventricular arrhythmia. Applications and limitations of noninvasive vs invasive approach.Chest, 1985
- Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmiaAmerican Heart Journal, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Suddent cardic death— Management of the patient at riskCurrent Problems in Cardiology, 1980
- Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.Circulation, 1980
- Ethmozin: A new antiarrhythmic agent developed in the USSR. Efficacy and toleranceAmerican Heart Journal, 1979
- New antiarrhythmic agents: Amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamilThe American Journal of Cardiology, 1978
- Acute oral testing for determining antiarrhythmic drug efficacy: I. QuinidineThe American Journal of Cardiology, 1976
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971